Delivery Order SPE2DB24D1021-SPE2DB25FFAAX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,118.80. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,848.18 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 1, 2025, for Valacyclovir HCL 1 Gram Tablet 90s. The contract is valued at $1,327.44 with a firm fixed price structure and an ultimate completion date of August 4, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to compete openly for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Valacyclovir HCL 1 gram, valued at $2,358.55 under a firm fixed price contract type. The award, effective July 31, 2025, with an ultimate completion date of August 1, 2025, was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract at its Corporate Office location and serve...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valacyclovir HCL 1 gram tablets. The contract has a firm fixed price of $2,019.74 and a period of performance through April 30, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Valacyclovir HCl 1 gram tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,940.28 fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of December 2, 2024 and was awarded on November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,170.91, is for the delivery of Valacyclovir HCL 1 gram tablets. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,235.08 firm fixed-price delivery order is for the provision of 90-count packages of the generic drug Valacyclovir HCL 1 gram tablets. The contract has an ultimate completion date of May 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,140.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,556,298,292 units of Valacyclovir HCL 500 mg tablets in 90-count packages. This delivery order was placed under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $1,077.59 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of valacyclovir hydrochloride, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31,...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAAXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,421.78. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, under a firm fixed-price contract structure with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contracting portfolio demonstrates extensive experience fulfilling competitive pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible delivery order mechanisms across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/27/25 |